These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 17192248

  • 1. Hard gelatin and hypromellose (HPMC) capsules: estimation of rupture time by real-time dissolution spectroscopy.
    El-Malah Y, Nazzal S, Bottom CB.
    Drug Dev Ind Pharm; 2007 Jan; 33(1):27-34. PubMed ID: 17192248
    [Abstract] [Full Text] [Related]

  • 2. Effect of fill weight, capsule shell, and sinker design on the dissolution behavior of capsule formulations of a weak acid drug candidate BMS-309403.
    Wu Y, Zhao F, Paborji M.
    Pharm Dev Technol; 2003 Jan; 8(4):379-83. PubMed ID: 14601962
    [Abstract] [Full Text] [Related]

  • 3. The in vitro dissolution of theophylline from different types of hard shell capsules.
    Podczeck F, Jones BE.
    Drug Dev Ind Pharm; 2002 Oct; 28(9):1163-9. PubMed ID: 12455475
    [Abstract] [Full Text] [Related]

  • 4. The shell dissolution of various empty hard capsules.
    Chiwele I, Jones BE, Podczeck F.
    Chem Pharm Bull (Tokyo); 2000 Jul; 48(7):951-6. PubMed ID: 10923822
    [Abstract] [Full Text] [Related]

  • 5. Performance qualification of a new hypromellose capsule: Part II. Disintegration and dissolution comparison between two types of hypromellose capsules.
    Ku MS, Lu Q, Li W, Chen Y.
    Int J Pharm; 2011 Sep 15; 416(1):16-24. PubMed ID: 21356291
    [Abstract] [Full Text] [Related]

  • 6. Influence of capsule shell composition on the performance indicators of hypromellose capsule in comparison to hard gelatin capsules.
    Al-Tabakha MM, Arida AI, Fahelelbom KM, Sadek B, Saeed DA, Abu Jarad RA, Jawadi J.
    Drug Dev Ind Pharm; 2015 Sep 15; 41(10):1726-37. PubMed ID: 25586554
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Time domain 1H NMR as a new method to monitor softening of gelatin and HPMC capsule shells.
    Kuentz M, Rothenhäusler B, Röthlisberger D.
    Drug Dev Ind Pharm; 2006 Sep 15; 32(10):1165-73. PubMed ID: 17090439
    [Abstract] [Full Text] [Related]

  • 10. A comparison of the puncturing properties of gelatin and hypromellose capsules for use in dry powder inhalers.
    Birchall JC, Jones BE, Morrissey A, Jones BE.
    Drug Dev Ind Pharm; 2008 Aug 15; 34(8):870-6. PubMed ID: 18686093
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Performance qualification of a new hypromellose capsule: part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus, Quali-V and gelatin capsules.
    Sherry Ku M, Li W, Dulin W, Donahue F, Cade D, Benameur H, Hutchison K.
    Int J Pharm; 2010 Feb 15; 386(1-2):30-41. PubMed ID: 19900518
    [Abstract] [Full Text] [Related]

  • 14. Predicting the human in vivo performance of different oral capsule shell types using a novel in vitro dynamic gastric model.
    Vardakou M, Mercuri A, Naylor TA, Rizzo D, Butler JM, Connolly PC, Wickham MS, Faulks RM.
    Int J Pharm; 2011 Oct 31; 419(1-2):192-9. PubMed ID: 21843611
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of particle size, food, and capsule shell composition on the oral bioavailability of dabrafenib, a BRAF inhibitor, in patients with BRAF mutation-positive tumors.
    Ouellet D, Grossmann KF, Limentani G, Nebot N, Lan K, Knowles L, Gordon MS, Sharma S, Infante JR, Lorusso PM, Pande G, Krachey EC, Blackman SC, Carson SW.
    J Pharm Sci; 2013 Sep 31; 102(9):3100-9. PubMed ID: 23608920
    [Abstract] [Full Text] [Related]

  • 17. Modified conventional hard gelatin capsules as fast disintegrating dosage form in the oral cavity.
    Ciper M, Bodmeier R.
    Eur J Pharm Biopharm; 2006 Feb 31; 62(2):178-84. PubMed ID: 16260126
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Coated hard capsules as the pH-dependent drug transport systems to ileo-colonic compartment.
    Dvořáčková K, Rabišková M, Muselík J, Gajdziok J, Bajerová M.
    Drug Dev Ind Pharm; 2011 Oct 31; 37(10):1131-40. PubMed ID: 21417619
    [Abstract] [Full Text] [Related]

  • 20. The disintegration behaviour of capsules in fed subjects: a comparison of hypromellose (carrageenan) capsules and standard gelatin capsules.
    Jones BE, Basit AW, Tuleu C.
    Int J Pharm; 2012 Mar 15; 424(1-2):40-3. PubMed ID: 22214655
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.